Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report

• Main Authors: Nataliya Babyshkina (Author), Nataliya Popova (Author), Evgeny Grigoryev (Author), Tatyana Dronova (Author), Polina Gervas (Author), Alexey Dobrodeev (Author), Dmitry Kostromitskiy (Author), Victor Goldberg (Author), Sergei Afanasiev (Author), Nadejda Cherdyntseva (Author)
• Format: Book
• Published: AboutScience Srl, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immunotherapy has become an integral part of a comprehensive treatment approach to metastatic colorectal cancer (mCRC). Nivolumab (Opdivo) is a human immunoglobulin G4 monoclonal antibody that blocks the interaction between the programmed cell death 1 (PD-1) receptor and its ligands 1/2 (PD-L1/PD-L2...